INSM Q2 2021 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$45M+6.8% YoY

Gross Profit

$35M76.1% margin

Operating Income

-$89M-195.2% margin

Net Income

-$117M-258.6% margin

EPS (Diluted)

$-1.07

QoQ Revenue Growth

+12.8%

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$79M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$699M

Stockholders' Equity

$531M

Cash & Equivalents

$928M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$42M	+6.8%
Gross Profit	$35M	$33M	+6.1%
Operating Income	-$89M	-$54M	-63.7%
Net Income	-$117M	-$62M	-89.7%